Deutsche Bank AG purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,005,780 shares of the company’s stock, valued at approximately $238,933,000. Deutsche Bank AG owned 0.43% of Cardinal Health at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. University of Texas Texas AM Investment Management Co. acquired a new stake in Cardinal Health in the fourth quarter valued at approximately $26,000. Bank of Jackson Hole Trust purchased a new stake in shares of Cardinal Health in the 4th quarter valued at approximately $27,000. Jones Financial Companies Lllp raised its holdings in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares in the last quarter. Palladiem LLC acquired a new stake in shares of Cardinal Health in the 4th quarter valued at $28,000. Finally, Indiana Trust & Investment Management Co purchased a new stake in shares of Cardinal Health during the 1st quarter worth $29,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.
Cardinal Health Price Performance
CAH stock opened at $234.85 on Wednesday. The company has a market cap of $54.62 billion, a price-to-earnings ratio of 32.48, a price-to-earnings-growth ratio of 1.26 and a beta of 0.49. The company has a fifty day moving average price of $231.38 and a 200 day moving average price of $217.51. Cardinal Health, Inc. has a 12 month low of $145.87 and a 12 month high of $258.30.
Cardinal Health Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be given a $0.5158 dividend. This represents a $2.06 annualized dividend and a yield of 0.9%. The ex-dividend date is Thursday, October 1st. Cardinal Health’s payout ratio is 28.49%.
Analyst Ratings Changes
A number of equities analysts recently commented on the stock. William Blair began coverage on shares of Cardinal Health in a research note on Tuesday, April 28th. They set an “outperform” rating for the company. UBS Group lifted their price target on Cardinal Health from $274.00 to $280.00 and gave the stock a “buy” rating in a report on Wednesday, August 12th. Zacks Research cut Cardinal Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 12th. Mizuho increased their price objective on Cardinal Health from $240.00 to $250.00 and gave the company an “outperform” rating in a report on Wednesday, August 12th. Finally, Weiss Ratings raised Cardinal Health from a “buy (b)” rating to a “buy (b+)” rating in a research report on Wednesday, August 5th. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and an average target price of $265.93.
Read Our Latest Report on Cardinal Health
About Cardinal Health
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Featured Stories
- Five stocks we like better than Cardinal Health
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
